Pharmaceuticals

IATI CEOs Forum meets in Kiryat Gat to discuss multinational industry resilience

The meeting at HP Indigo focused on “full-scope companies,” multinationals that combine R&D, manufacturing, operations, exports, and global support in Israel.

Noam Zilbershtain, senior vice president and general manager, HP Indigo; Adi Soffer Teeni, CEO of Meta Israel, vice president and member of the EMEA leadership team; and Karin Mayer Rubinstein, CEO and president of IATI.
Mrs. Glassman enjoys a cup of coffee at one of the Jerusalem cafés she frequented

A Passover tribute: Kindness from a Jerusalem neighborhood pharmacy

 Illustration photo of Super Pharm drug store and pharmacy at the Hadar mall in Jerusalem, on April 30, 2018.

New immigrant pharmacists face discrimination, lack of gov't support despite professional shortage

Or Biba is the founder and VP of business development at EcoSupp.

EcoSupp listens, learns, and delivers


Israeli health officials call for sanctions on anti-vaxxers as flu morbidity rate rises

Only 17% of Israelis have been vaccinated; health fund CEOs are divided over sanctions versus accessibility.

A patient at a Maccabi Health Center in Jerusalem receives a vaccination against the 'H1N1' swine flu. Israeli health authorities has started vaccinating the population against swine flu. December 20, 2009.

Israel's biotech moment: How science, data, and geopolitics are converging - opinion

Why now Is the time to invest in a deeply built, undervalued market

Automated pharmaceutical conveyor line, robotic arms handling medical vials

From Auschwitz to Dachau: How a pharmacist became central to Nazi camp medical crimes - study

The authors explore how pharmaceutical logistics and networks enabled neglect, experimentation, and killings in the camp medical system.

The entrance of the former German Nazi concentration camp in Dachau near Munich, Germany.

EU Council and Parliament reach agreement to overhaul drug rules, speed patient access

The agreement grants companies launching new medicines eight years of data protection for trial results and one year of market protection.

Used blister packets that contained medicines, tablets and pills are seen, in this picture illustration taken June 30, 2018.

Israeli gas sensor spots ‘mirror’ molecules, opening path to breath-based diagnostics

By detecting subtle structural differences in volatile compounds, the sensors could power non-invasive breath tests for diseases such as lung cancer or diabetes.

The Hebrew University of Jerusalem. October 20, 2015.

Novo Nordisk advances amycretin to late-stage trial after positive diabetes weight-loss results

Novo Nordisk’s experimental drug amycretin shows strong results in its mid-stage trial, helping type 2 diabetes patients lose up to 14.5% of their body weight.

The logo of pharmaceutical company Novo Nordisk is displayed in front of its offices in Bagsvaerd, on the outskirts of Copenhagen, Denmark, November 24, 2025.

Teva seeks startups to help solve global pharmaceutical challenges

Called Teva Rise, it aims to accelerate innovations such as AI, digital health, smart manufacturing and biotech

Logo of Teva Pharmaceutical

Trump warns pharmaceutical tariffs could reach 200%, gives 'a year to get their act together'

US President Donald Trump plans to implement a 200% tariff rate on pharmaceuticals, while he also announced tariffs on semiconductors and copper.

 US PRESIDENT Donald Trump in the Oval Office last Friday: Since Trump’s election as president last November for a second term, the US has no longer been committed to the previous world order in which it had played such a major role in creating and running, the writer maintains.

Israel’s healthcare workforce lags behind OECD averages despite growth in doctors and nurses

Despite an increase in medical professionals, Israel’s healthcare workforce remains below the OECD average, highlighting ongoing challenges.

Doctor holds a stethoscope in front of a hospital background (illustrative)

Teva share price struggles to recover following $6 billion market loss

The financial results were actually positive, at the higher end of analysts' forecasts, but profit guidance for 2025 disappointed the market.

 Pills on health form